Is matcha good for heart health?

Research suggests matcha may support cardiovascular health through several distinct mechanisms, including reduced oxidative stress, lower LDL cholesterol, better blood pressure regulation, and improved endothelial function. Most of the available evidence draws from studies on brewed green tea or isolated green tea catechins. Because matcha is consumed as a whole-leaf powder, it delivers a higher concentration of these compounds — which adds to its potential relevance, though human trials specifically on matcha and heart health remain limited.

The active compounds most studied in relation to heart health are catechins, a class of antioxidant polyphenols. The most abundant catechin in matcha is epigallocatechin gallate (EGCG), which has been extensively researched for its cardiovascular effects. Matcha also contains antioxidants beyond EGCG, as well as amino acids and chlorophyll, though the catechin research is the most clinically developed.

Oxidative stress — an imbalance between the production of reactive oxygen species and the body's capacity to neutralise them — is a significant factor in the development of cardiovascular disease. High levels of oxidative stress can damage cells, contribute to inflammation, and promote the formation of atherosclerotic plaques in blood vessels.

Matcha is a rich source of catechins, which have been shown to neutralise reactive oxygen species and reduce oxidative stress. Khan and Mukhtar (2018), reviewing the cardiovascular research on EGCG, noted that its antioxidant activity is considerably more potent than that of vitamins C and E.

A study by Suzuki-Sugihara et al. (2016) specifically examining matcha — rather than brewed green tea — found that consuming matcha significantly increased the antioxidant capacity of participants. Crucially, the researchers found that catechins from matcha accumulated within LDL particles themselves, suggesting a direct protective mechanism against LDL oxidation, which is an early step in cardiovascular disease development.

Evidence from multiple randomised trials and meta-analyses suggests regular green tea consumption reduces both total and LDL cholesterol. Matcha, as a whole-leaf preparation, delivers a higher catechin concentration than brewed tea.

Several meta-analyses have examined the relationship between green tea consumption and LDL cholesterol. Zheng et al. (2011) conducted a meta-analysis of 14 randomised controlled trials and found that green tea consumption was associated with significant reductions in both total and LDL cholesterol in adults. The effect was consistent across studies and appeared dose-dependent.

A study by Nagao et al. (2007) involving 240 participants found that daily consumption of a catechin-rich green tea beverage led to measurable reductions in LDL cholesterol over 12 weeks. Given that matcha delivers a higher concentration of catechins than standard brewed green tea — because you consume the whole leaf rather than discarding it — the potential impact on cholesterol may be proportionally greater, though this has not yet been confirmed in dedicated matcha trials.

For context on how matcha differs from regular green tea in terms of catechin concentration, the whole-leaf preparation method is the key factor.

Research on green tea consistently shows modest reductions in systolic and diastolic blood pressure. The effect is meaningful as part of a broader dietary pattern but is unlikely to replace medical management of hypertension.

High blood pressure is a significant risk factor for cardiovascular events. Research suggests that regular green tea consumption may be associated with modest but meaningful reductions in blood pressure.

Liu et al. (2014) conducted a meta-analysis of 13 randomised controlled trials and found that green tea consumption was associated with a significant reduction in both systolic and diastolic blood pressure. The authors proposed that catechins, particularly EGCG, may contribute to these effects through their influence on endothelial function and vasodilation — effects that are also observed with L-theanine, which reduces vascular resistance.

The blood pressure effects observed in the research are generally modest in magnitude — in the range of a few millimetres of mercury — and are unlikely to replace medical management for those with diagnosed hypertension. The research is most relevant as evidence that regular consumption may contribute to a broader pattern of cardiovascular support.

The endothelium — the thin layer of cells lining blood vessels — plays a central role in regulating blood pressure, clotting, and vascular inflammation. Endothelial dysfunction is an early marker of cardiovascular disease, and improving endothelial function is considered a meaningful target for cardiovascular health.

EGCG has been found to increase the production of nitric oxide in endothelial cells. Nitric oxide promotes relaxation of blood vessel walls, improving blood flow and reducing the mechanical stress that contributes to vascular damage. Schini-Kerth et al. (2010) demonstrated that polyphenols, including those from green tea, stimulate endothelial nitric oxide production through both direct enzyme activation and antioxidant mechanisms.

A clinical study by Widlansky et al. (2007) found that short-term supplementation with green tea extract — standardised for catechin content — reversed endothelial dysfunction in patients with coronary artery disease, as measured by flow-mediated dilation. The results suggest that even acute catechin exposure can produce measurable improvements in vascular function.

At a standard 2g serve, unlikely for most people. Matcha's caffeine is moderate and is tempered by L-theanine. Those sensitive to caffeine or with existing cardiac conditions should consult their GP.

A common question, and a fair one to address directly. A standard 2g serve of matcha contains 60–80mg of caffeine. For comparison, a standard espresso contains roughly 60–75mg. Matcha's caffeine content is therefore moderate, and for most people it is well within a comfortable daily range.

Caffeine does increase heart rate transiently in some people, particularly those who are sensitive to it or who consume it in large amounts. At normal serving sizes, this effect is mild and temporary for most people. The presence of L-theanine in matcha may also moderate some of caffeine's stimulant effects, including the tendency toward anxiety or palpitations.

If you notice your heart rate increasing or feel palpitations after drinking matcha, reducing the amount per serve or switching to one serve per day is a sensible first step. Those with existing heart conditions, arrhythmias, or who are on medication that affects heart rate should speak with their GP before adding matcha — or any caffeinated drink — regularly to their diet. Matcha is not a clinical concern for most healthy adults, but caffeine sensitivity varies considerably between individuals.

One to three serves of 2g per day delivers a meaningful catechin dose. The evidence points to consistency over time rather than a specific daily target.

The population studies on green tea and cardiovascular outcomes — including the Ohsaki cohort study by Kuriyama et al. (2006), which followed more than 40,000 Japanese adults and found that consuming five or more cups of green tea per day was associated with lower cardiovascular mortality — tend to involve habitual, multi-cup daily consumption over years.

That level of consumption is achievable with brewed tea but is less practical with matcha. One to three serves of matcha per day (using a standard 2g measure) delivers a meaningful catechin dose and falls comfortably within a healthy caffeine range for most adults. The evidence does not point to a precise threshold — consistency over time appears to matter more than a specific daily target.

Matcha is best understood as one part of a broader pattern of dietary and lifestyle choices that support cardiovascular health, not as a standalone intervention. A diet with adequate vegetables, fibre, and unsaturated fats remains foundational. For more on what makes matcha distinct from other tea options, see our matcha health benefits overview.

---

The research on matcha and heart health is promising across several mechanisms, from cholesterol and blood pressure to endothelial function and oxidative stress. None of this positions matcha as a treatment, but the evidence for its role as part of a thoughtful daily routine is well-grounded. Our single-origin Japanese matcha is grown and processed to preserve the catechin content that makes it worth drinking.